
Advent to exit GTCR in €4.1bn sale to GTCR
Advent International has agreed to sell Czech generic drugmaker Zentiva to Chicago-based private equity firm GTCR in a €4.1bn deal, marking one of Europe’s largest healthcare transactions this year, according to a report by the Financial Times.

